ASX:BIO

Biome Australia (BIO) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free BIO Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Biome Australia alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Biome Australia

Biome Australia Limited develops, commercializes, and markets various live biotherapeutics and complimentary medicines in Australia and internationally. It provides live biotherapeutic products under the Activated Probiotics brand; organic nutraceutical products under the Activated Nutrients brand; and sports performance and recovery products under the Activated X Performance brand. The company markets its products through community pharmacies, independent health practitioners, and health professionals. Biome Australia Limited was incorporated in 2018 and is based in Cremorne, Australia.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

BIO Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive BIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biome Australia and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Consumer Defensive
Industry: Packaged Foods
Sub-Industry: N/A
Current Symbol: ASX:BIO
CUSIP: N/A
CIK: N/A
Web: www.bio-rad.com
Phone: 15107247000
Fax: N/A
Employees: 30
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): A($0.01)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-2,860,000.00
Net Margins: -29.03%
Pretax Margin: N/A
Return on Equity: -82.81%
Return on Assets: -28.55%

Debt

Debt-to-Equity Ratio: 67.56
Current Ratio: 1.40
Quick Ratio: 4.65

Sales & Book Value

Annual Sales: $9.87 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: A$0.01 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 212,010,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 1.56

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Mr. Blair William Brabin Vega Norfolk (Age 39)
MD, CEO & Director
Comp: $528.68k
Mr. Douglas Chee Yong Loh CPA
Chief Financial Officer
Dr. Jaroslav Haman Boublik
Chief Science Officer & Member of Scientific Advisory Board
Mr. George Lazarou ACA
BCom, Company Secretary

Key Competitors

View All Competitors

Insiders

Dominique Fisher
Sold 1,011,864 shares
Total: $122,435.54 ($0.12/share)

This page (ASX:BIO) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Biome Australia (BIO) Stock Price, News & Analysis

About Biome Australia

BIO Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info